This first of December, we’re recognizing World Aids Day by sharing the latest research from Children’s Hospital of Philadelphia investigators who partnered with the University of Pennsylvania, the University of Botswana, and the Botswana Ministry of Health through the Botswana-UPenn partnership, in order to address sub-Saharan Africa’s HIV/AIDS epidemic. Alongside their findings published last week, our news roundup also includes special congratulations to Diva De León-Crutchlow, MD, on a “sweet” new award from Congenital Hyperinsulinism International, and novel research findings from our investigators who study cardiology, genetics, and puberty.
Tag Archive: Babette Zemel
Bone mineral accrual doesn’t keep pace with height growth prior to adolescence, according to a national study. After a teenager reaches adult height, bone mineral accrual tends to play catch-up: Roughly 10 percent of bone mass continues to accumulate after height growth is complete. The study findings also suggest that bone growth is site-specific, with bone mineral density developing at different rates in different parts of the skeleton.
Not all superheroes wear masks and capes. At Children’s Hospital of Philadelphia, clinical research coordinators are the often-unsung superheroes doing important work in plain clothes and in plain sight.
Not every child who comes to the hospital is sick. Some of the families who visit The Children’s Hospital of Philadelphia on a regular basis are voluntary participants in research studies. Clinical research studies are an essential component of pediatric research that can lead to novel discoveries and advancements for populations in need.
Our news highlights this week include new evidence-based sleep recommendations; a new champion for helping military families navigate children’s healthcare issues; a lifesaving solution to a mysterious surgical side effect; and an encouraging finding to help children predisposed to fragile bones grow up stronger.
Every week is full of discovery at The Children’s Hospital of Philadelphia. Among the highlights this week are a significant discovery and new treatment option in a heart surgery complication that affects young patients; a study of how to predict infants’ later obesity risk; and a CHOP cancer immunotherapy story hitting the world stage at an international conference.
News abounds this first week of spring, and we bring you fresh insights from new scientific studies cultivated by experts at The Children’s Hospital of Philadelphia. But first, take a moment to celebrate a special award that recognizes the dedication of pediatric oncologist Richard Aplenc, MD, PhD, MSCE.
Children with Down syndrome (also known as Trisomy 21) are prone to obesity. Their families may be concerned about their future risks for cardiovascular problems as well as their quality of life.
Many of today’s healthy children and teens will develop later-onset chronic conditions including heart disease, cancer, and osteoporosis.
Pediatricians have long known that children with Down syndrome grow differently than typical children, but the last growth charts for children with Down syndrome were developed almost 30 years ago.